1.
RP215在NSCLC中的表达及临床特征分析
Association between RP215 expression and clinicopathological features of lung cancer patients
| Characteristics | Number of cases (%) | RP215 | P | ||||
| Low | High | ||||||
| NSCLC: non-small cell lung cancer. | |||||||
| Age (yr) | 0.729 | ||||||
| ≥60 | 26 (36.1) | 8 | 18 | ||||
| < 60 | 46 (63.9) | 16 | 30 | ||||
| Gender | 1.000 | ||||||
| Male | 54 (75.0) | 20 | 34 | ||||
| Female | 18 (25.0) | 6 | 12 | ||||
| Pathological type | 0.632 | ||||||
| Squamous | 44 (61.1) | 17 | 27 | ||||
| Adenocarcinoma | 28 (38.9) | 9 | 19 | ||||
| Clinical stage | 0.042 | ||||||
| Ⅰ | 20 (27.8) | 9 | 11 | ||||
| Ⅱ | 12 (16.7) | 6 | 6 | ||||
| Ⅲ | 24 (33.3) | 10 | 14 | ||||
| Ⅳ | 16 (22.2) | 1 | 15 | ||||
| T classification | 0.044 | ||||||
| T1 | 12 (16.7) | 8 | 4 | ||||
| T2 | 34 (47.2) | 9 | 25 | ||||
| T3 | 26 (36.1) | 9 | 17 | ||||
| N classification | 0.594 | ||||||
| N0 | 36 (50.0) | 15 | 21 | ||||
| N1 | 10 (13.9) | 4 | 6 | ||||
| N2 | 14 (19.4) | 3 | 11 | ||||
| N3 | 12 (16.7) | 4 | 8 | ||||
| Metastasis | 0.007 | ||||||
| No | 56 (77.8) | 24 | 32 | ||||
| Yes | 16 (22.2) | 1 | 15 | ||||